What is Teladoc Health Interest Expense?
Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Teladoc Health's interest expense for the
three
months ended in Sep. 2024 was $ -6 Mil.
Its interest expense for the trailing twelve months (TTM) ended in Sep. 2024 was $-22 Mil.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Teladoc Health's Operating Income for the
three
months ended in Sep. 2024 was $ -40 Mil. Teladoc Health's Interest Expense for the
three
months ended in Sep. 2024 was $ -6 Mil.
Teladoc Health did not have earnings to cover the interest expense.
The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.
Teladoc Health Interest Expense Calculation
Interest Expense is the amount reported by a company or individual as an expense for borrowed money.
Interest Expense for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-22 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Teladoc Health (NYSE:TDOC) Interest Expense Explanation
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.
Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.
Teladoc Health's Interest Expense for the
three
months ended in Sep. 2024 was $-6 Mil. Its
Operating Income
for the
three
months ended in Sep. 2024 was $-40 Mil. And its Long-Term Debt & Capital Lease Obligation for the
three
months ended in Sep. 2024 was $1,027 Mil.
Teladoc Health's Interest Coverage for the quarter that ended in Sep. 2024 is calculated as
| Teladoc Health did not have earnings to cover the interest expense. |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The higher the ratio, the stronger the company's financial strength is.
Teladoc Health Business Description
Traded in Other Exchanges
Address
2 Manhattanville Road, Suite 203, Purchase, NY, USA, 10577
Teladoc Health is a virtual health provider with a telehealth platform delivering on-demand healthcare via mobile devices, the internet, video, and phone. It also offers remote patient monitoring programs for chronic care management. It operates in Teladoc two segments Health Integrated Care and BetterHelp segments. The majority of its revenue generated from access fees on a subscription basis (per member, per month). The balance comes from visit fees and equipment rental and sales to hospital systems. Since inception, Teladoc has partnered with employers, health plans, and health systems to offer network access to their members; it has also started to market directly to consumers while expanding its service portfolio.
Executives
| Mala Murthy |
officer: Chief Financial Officer |
C/O TELADOC HEALTH, INC., 2 MANHATTANVILLE ROAD, SUITE 203, PURCHASE NY 10577 |
| Adam C Vandervoort |
officer: Chief Legal Officer, Secretary |
485 MADISON AVENUE, NEW YORK NY 10022 |
| Thomas Mckinley |
director |
|
| Andrew Turitz |
officer: SVP - Business Development |
C/O TELADOC, INC., 2 MANHATTANVILLE ROAD, SUITE 203, PURCHASE NY 10577 |
| Vidya Raman-tangella |
officer: Chief Medical Officer |
2 MANHATTANVILLE ROAD, SUITE 203, PURCHASE NY 10577 |
| Michael Willem Waters |
officer: CHIEF OPERATING OFFICER |
2 MANHATTANVILLE ROAD, SUITE 203, PURCHASE NY 10577 |
| Stephany Verstraete |
officer: Chief Marketing Officer |
C/O TELADOC, INC., 2 MANHATTANVILLE ROAD, SUITE 203, PURCHASE NY 10577 |
| Arnnon Geshuri |
officer: Chief Human Resources Officer |
2 MANHATTANVILLE ROAD, SUITE 203, PURCHASE NY 10577 |
| Daniel Trencher |
officer: SVP Corporate Strategy |
2 MANHATTANVILLE ROAD, SUITE 203, PURCHASE NY 10577 |
| Mark Douglas Smith |
director |
C/O TELADOC HEALTH, INC., 2 MANHATTANVILLE ROAD, SUITE 203, PURCHASE NY 10577 |
| Laizer Kornwasser |
officer: PRESIDENT, ENTERPRISE GROWTH |
100 PARSONS POND DRIVE, FRANKLIN LAKES NJ 07417 |
| Karen L Daniel |
director |
2801 80TH STREET, KENOSHA WI 53141 |
| Jason N Gorevic |
director, officer: President & CEO |
|
| Richard J Napolitano |
officer: Chief Accounting Officer |
MSCI INC., 7 WORLD TRADE CENTER, 250 GREENWICH STREET, 49TH FLOOR, NEW YORK NY 10007 |
| Jason Eric Evans |
director |
310 SEVEN SPRINGS WAY, SUITE 500, BRENTWOOD TN 37027 |
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
TDOC has been successfully added to your 